JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2022. Vol. 67. № 5
DOI: 10.33266/1024-6177-2022-67-5-41-46
E.A. Kodintseva1, 2, A.А. Akleyev3
EFFECT OF CHRONIC EXPOSURE AND NON-RADIATION FACTORS ON THE INTRACELLULAR STAT3 CONCENTRATION
1Urals Research Center for Radiation Medicine, Chelyabinsk, Russia
2Chelyabinsk State University, Chelyabinsk, Russia
3Southern-Urals State Medical University of the RF Ministry of Public Health, Chelyabinsk, Russia
Contact person: Е.А. Kodintseva, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To evaluate the influence of radiation and non-radiation factors on the intracellular concentration of the transcription factor STAT3 in peripheral blood lymphocytes of chronically irradiated residents of the coastal villages of the Techa River in the long-term after the onset of irradiation.
Material and methods: The main group consisted of 50 people aged 67 to 84 years old with an average dose of irradiation of the red bone marrow of 727.9±79.1 mGy; thymus and peripheral lymphoid organs – 85.9±13.6 mGy. The comparison group included 25 people aged from 61 to 87 who were not exposed to accidents, whose distribution by sex and ethnicity corresponded to the composition of the main group. Peripheral blood lymphocyte lysates were normalized for total protein concentration prior to enzyme immunoassay.
Results: The median intracellular concentration of STAT3 was 167.6 (118.3–240.1) pg/ml in the main group and 147.0 (116.7–179.2) pg/ml in the control group.
Conclusion: The intracellular level of STAT3 did not differ significantly between chronically exposed and non-exposed individuals, as well as in people from different dose subgroups. Correlations between the concentration of STAT3 and dose characteristics, gender and ethnicity of the examined people were not found. In people with a red bone marrow dose of 0.85 Gy or more, STAT3 concentration correlated with age at the time of examination (SR= ‒0.67, p=0.01). In other dose subgroups, no correlation was found between the estimated indicator and the achieved age. The results are preliminary.
Keywords: chronic radiation exposure, the Techa River, transcription factor STAT3, intracellular concentration, peripheral blood lymphocytes
For citation: Kodintseva ЕА, Akleyev АА. Effect of Chronic Exposure and Non-Radiation Factors on the Intracellular STAT3 Concentration. Medical Radiology and Radiation Safety. 2022;67(5):41–46. (In Russian). DOI: 10.33266/1024-6177-2022-67-5-41-46
References
1. Akleyev A.V., Varfolomeyeva T.A. Status of Hematopoiesis in Residents of the Techa Riverside Villages. Posledstviya Radioaktivnogo Zagryazneniya Reki Techi = Consequences of Radioactive Contamination of the Techa River. Ed. Prof. Akleyev A.V. Chelyabinsk, Kniga Publ., 2016. Р. 166-194. (In Russ.). DOI: 10.7868/S0869803117020060.
2. Krestinina L.Yu., Silkin S.S., Mikryukova L.D., Yepifanova S.B., Akleyev A.V. Risk of Death from Solid Cancer among Residents of the Techa Riverside and the East Urals Radioactive Trace Areas Exposed to Radiation. Comparative analysis. Radiatsiya i Risk = Radiation and Risk. 2017;26;1:100-114
(In Russ.). DOI: 10.21870/0131-3878-2017-26-1-100-114.
3. Marchal J., Pifferi F., Aujard F. Resveratrol in Mammals: Effects on Aging Biomarkers, Age-Related Diseases, and Life Span. Annals of the New York Academy of Sciences. 2013;1290;1:67–73. DOI: 10.1111/nyas.12214.
4. Beebe J., Liu J.-Y., Zhang J.-T. Two Decades of Research in Discovery of Anticancer Drugs Targeting Stat3, how Close Are we? Pharmacology & Therapeutics. 2018;191:74-91. DOI: 10.1016/j.pharmthera.2018.06.006.
5. Wang X., Zhang X., Qiu C., Yang N. STAT3 Contributes to Radioresistance in Cancer. Frontiers in Oncology. 2020;10:1120. DOI: 10.3389/fonc.2020.01120.
6. Li F., Gao L., Jiang Q., Wang Z., Dong B., Yan T., et al. Radiation enhances the invasion abilities of pulmonary adenocarcinoma cells via STAT3. Molecular Medicine Reports. 2013;7:1883-1888. DOI: 0.3892/mmr.2013.1441.
7. Gao L., Li F.-S., Chen X.-H., Liu Q.-W., Feng J.-B., Liu Q.-J., et al. Radiation Induces Phosphorylation of STAT3 in a Dose- and Time-Dependent Manner. Pacific Journal of Cancer Prevention. 2014;15:6161-6164. DOI: 10.7314/apjcp.2014.15.15.6161.
8. Jones L.M., Broz M.L., Ranger J.J., Ozcelik J., Ahn R., Zuo D., et al. STAT3 Establishes an Immunosuppressive Microenvironment During the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis. Cancer Research. 2016;76:1416-1428. DOI: 0.1158/0008-5472.CAN-15-2770.
9. Oweida A.J., Darragh L., Phan A., Binder D., Bhatia S., Mueller A., et al. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer. Journal of the National Cancer Institute. 2019;111;12:1339-1349. DOI: 10.1093/jnci/djz036.
10. Hossain D.M., Panda A.K., Manna A. Mohanty S., Bhattacharjee P., Bhattacharyya S., et al. FoxP3 Acts as a Co-Transcription Factor with STAT3 in Tumor-Induced Regulatory T Cells. Immunity. 2013;39;6:1057-1069. DOI: 10.1016/j.immuni.2013.11.005.
11. Siegel A.M., Heimall J., Freeman A.F., Hsu A.P., Brittain E., Brenchley J.M., et al. A Critical Role for STAT3 Transcription Factor Signaling in the Development and Maintenance of Human T Cell Memory. Immunity. 2011;35;5:806-818. DOI: 10.1016/j.immuni.2011.09.016.
12. Goswami R., Kaplan M.H. STAT Transcription Factors in T Cell Control of Health and Disease. International Review of Cell and Molecular Biology. 2016;331:123-180. DOI: 10.1016/bs.ircmb.2016.09.012.
13. Akleyev A.V. Chronic Radiation Syndrome. Berlin-Heidelberg, Springer, 2014. 410 p. DOI: https://doi.org/10.1007/978-3-642-45117-1.
14. Degteva M.O., Napye B.A., Tolstykh Ye.I., Shishkina Ye.A., Bugrov N.G., Krestinina L.Yu., et al. Individual Dose Distribution in Cohort of People Exposed as a Result of Radioactive Contamination of the Techa River. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2019;64;3:46-53. (In Russ.). DOI: 10.12737/article_5cf2364cb49523.98590475.
15. Lymphocytes. A Practical Approach. Ed. Klaus G.G. Oxford University Press, 1987. 284 p.
16. Grzhibovskiy A.M., Ivanov S.V., Gorbatova M.A. Correlation Analysis of Data Using Statistica and SPSS Software. Nauka i Zdravookhraneniye = Science & Healthcare. 2017;1:7-36.
(In Russ.). DOI: 10.34689/SH.2017.19.1.001.
17. Su Y.L., Banerjee S., White S.V., Kortylewski M. STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity. International Journal of Molecular Sciences. 2018;19;6:1803. DOI: 10.3390/ijms19061803.
18. Arnold K.M., Opdenaker L.M., Flynn N.J., Appeah D.K., Sims-Mourtada J. Radiation Induces an Inflammatory Response that Results in Stat3-Dependent Changes in Cellular Plasticity and Radioresistance of Breast Cancer Stem-Like Cells. International Journal of Radiation Biology. 2020;96;4:434-447. DOI: 10.1080/09553002.2020.1705423.
19. Marotta L.L.C., Almendro V., Marusyk A., Shipitsin M., Schemme J., Walker S.R., et al. The JAK2/STAT3 Signa-
ling Pathway is Required for Growth of CD44+ CD24− Stem Cell-Like Breast Cancer Cells in Human Tumors. Journal of Clinical Investigation. 2011;121;7:2723-2735. DOI: 10.1172/JCI44745.
20. Lumniczky K., Impens N., Armengol G., Cand´eias S., Georgakilas A.G., Hornhardtf S., et al. Low Dose Ionizing Radiation Effects on the Immune System. Environment International. 2021;149:106212. DOI: 0.1016/j.envint.2020.106212.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.06.2022. Accepted for publication: 25.08.2022.